Changes in Bacteroides and the microbiota in patients with obstructed colorectal cancer: retrospective cohort studyOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This retrospective cohort study investigated whether intestinal obstruction caused by colorectal cancer (CRC) is associated with distinct changes in the gut microbiota. Researchers used 16S rRNA sequencing to compare microbiota composition in tumour and adjacent normal tissues between CRC patients with and without obstruction. Patients with and without obstruction were matched using 1:1 propensity score matching to reduce confounding. The study also examined whether obstruction status was linked to differences in survival outcomes.
Who was studied?
A total of 313 patients with colorectal cancer were recruited for the study. Total DNA was extracted and amplified from tumour and adjacent normal tissues of 84 patients, along with 36 additional frozen tumour tissue samples. Patients were divided into obstruction and non-obstruction groups and compared after propensity score matching. The abstract does not specify additional demographic details such as age or sex distribution.
What were the most important findings?
Patients with CRC-related intestinal obstruction had shorter overall survival and disease-free survival than those without obstruction. Microbial richness and diversity in tumour tissues were significantly higher in the obstruction group, with both alpha and beta diversity differing significantly between groups (P < 0.05). At the phylum and genus levels, Bacteroidetes were significantly enriched in the tumour tissues of patients with obstruction. The abstract does not mention Desulfovibrio, sulfate-reducing bacteria, hydrogen sulfide, or sulfur metabolism.
What are the greatest implications of this study?
The findings suggest that intestinal obstruction in colorectal cancer is associated with a distinct, more diverse tumour-associated microbiota dominated by Bacteroidetes, and with worse clinical outcomes. This raises the possibility that microbiota alterations may be a marker of, or contributor to, the more aggressive clinical course seen in obstructed CRC. These associations could inform future research into microbiota-based prognostic markers or risk stratification for CRC patients presenting with obstruction. Further studies would be needed to clarify causality and underlying mechanisms.